FDA Adverse Event
Injury
Summary report: N
NEUROMARK SYSTEM
MDR report key: 24529335
·
Received March 6, 2026
Report
- Report Number
- 3016813690-2026-00002
- Event Type
- Injury
- Date Received
- March 6, 2026
- Date of Event
- January 22, 2026
- Report Date
- March 6, 2026
- Manufacturer
- NEURENT MEDICAL LTD.
- Product Code
- GEI
- PMA / PMN Number
- K250048
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Additional Manufacturer Narrative · 0
BLEEDING IS A KNOWN POTENTIAL ADVERSE EVENT AND IS DOCUMENTED IN THE DEVICE LABELLING.
Description of Event or Problem · 0
PATIENT EXPERIENCED SEVERE EPISTAXIS 2 WEEKS POST NEUROMARK PROCEDURE. PATIENT UNDERWENT RIGHT SPHENOPALATINE ARTERY LIGATION TO RESOLVE THE ISSUE. THERE HAS BEEN NO BLEEDING SINCE THIS PROCEDURE AND THE EVENT IS RESOLVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 92805 | NEUROMARK SYSTEM | RADIOFREQUENCY PROBE | GEI | NEURENT MEDICAL LTD. | NMK00301 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 59 YR | Female | Required Intervention| H |